ACE2 and COVID-19: Another study identified a correlation between highly increased ACE2 expression and heightened severity of COVID-19 with comorbidities such as hypertension, diabetes, cerebrovascular disease, coronary heart disease, pulmonary disease, and smoking (Fig. 4A) [97].